KMX-12456-77682
4 vaccinations
1 coded response
30 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 989 / WA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-28
- 2021-01-04
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: Difficulty focusing on tasksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-10
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2022-01-07
-
2022-09-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-24
- 2022-09-28
- 2022-10-07
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-12-14
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | Flu |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Difficulty focusing on tasks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release